GALT - Galectin Therapeutics Inc
IEX Last Trade
2.7
-0.040 -1.481%
Share volume: 190,705
Last Updated: Fri 30 Aug 2024 09:59:53 PM CEST
Research and Development in Biotechnology (except Nanobiotechnology):
0.21%
PREVIOUS CLOSE
CHG
CHG%
$2.74
-0.04
-1.46%
Summary score
25%
Profitability
25%
Dept financing
3%
Liquidity
50%
Performance
25%
Sector
Professional, Scientific, and Technical Services
Industry
Research and Development in Biotechnology (except Nanobiotechnology)
Long-term ratios 30-Jun-2016 - 30-Jun-2020
The data are presented for the financials results of the quarters of the last 4 years.
Return on equity
-62.77%
Return on assets
-32.05%
Return on sales
0%
Return on invested capital
209.98%
Total debt ratio
24.16%
Debt ratio change over timeo
-0.82%
Current Ratio
11.69%
Quick Ratio
0%
Cash Position Ratio
11.73%
Short-term ratios 30-Jun-2019 - 30-Jun-2020
The data are presented for the financials results of the quarters of the last year.
Return on equity
-10.53%
Return on assets
-9.81%
Return on sales
0%
Return on invested capital
246.01%
Total debt ratio
5.49%
Debt ratio change over timeo
-0.98%
Current Ratio
25.39%
Quick Ratio
0%
Cash Position Ratio
25.17%
Last quarter ratios 30-Jun-2020
The data are presented for the financials results of the last quarter.
Return on equity
-16.7%
Return on assets
-14.77%
Return on sales
0%
Return on invested capital
151.54%
Total debt ratio
10.42%
Debt ratio change over time
-0.97%
Current Ratio
9.62%
Quick Ratio
0%
Cash Position Ratio
9.54%
Performance ratios (change over 4 years) 30-Jun-2016 - 30-Jun-2020
The data are presented for the change financials results of the quarter of the last 4 years.
Return on equity
-148.27%
Return on assets
-122.8%
Return on sales
0%
Return on invested capital
10.69%
Total debt ratio
-81.99%
Debt ratio change over time
-0.82%
Current Ratio
3.69%
Quick Ratio
0%
Cash Position Ratio
3.66%
Compare in sector
The following table compares the individual analyzes for the other top 3 stocks within the same industry.
| Long-term ratios | GALT | ABBV | AMGN | REGN |
|---|---|---|---|---|
| Return on equity | -62.77% | -3.05% | 11.55% | 6.27% |
| Return on assets | -32.05% | 3.6% | 3.57% | 5.27% |
| Return on sales | 0% | 32.14% | 42.16% | 33.08% |
| Return on invested capital | 209.98% | 5.09% | 7.99% | 13.19% |
| Profitability | 25% | 37% | 68% | 60% |
| Total debt ratio | 24.16% | 101.18% | 74.11% | 29.58% |
| Debt ratio change over time | -0.82% | 6.09% | 6.03% | 1.53% |
| Dept financing | 6% | 50% | 43% | 14% |
| Current Ratio | 25.39% | 2.08% | 2.02% | 3.51% |
| Quick Ratio | 0% | 1.96% | 1.71% | 2.86% |
| Cash Position Ratio | 25.17% | 1.48% | 0.76% | 1.49% |
| Liquididy | 50% | 15% | 34% | 33% |
| Short-term ratios | GALT | ABBV | AMGN | REGN |
|---|---|---|---|---|
| Return on equity | -10.53% | -25.62% | 17.94% | 7.14% |
| Return on assets | -9.81% | 3.26% | 3.67% | 4.71% |
| Return on sales | 0% | 31.22% | 37.5% | 33.58% |
| Return on invested capital | 246.01% | 8.14% | 7.17% | 18.16% |
| Profitability | 25% | 39% | 70% | 59% |
| Total debt ratio | 5.49% | 105.33% | 83.42% | 27.49% |
| Debt ratio change over time | -0.98% | -23.44% | 9.66% | 0.6% |
| Dept financing | 1% | 25% | 45% | 8% |
| Current Ratio | 25.39% | 2.08% | 2.02% | 3.51% |
| Quick Ratio | 0% | 1.96% | 1.71% | 2.86% |
| Cash Position Ratio | 25.17% | 1.48% | 0.76% | 1.49% |
| Liquididy | 50% | 21% | 18% | 30% |